# DScale: Scaling Block-Diffusion Speculative Decoding with Adaptive Verification

Preprint · Rongjian Chen, Minxian Xu, Zhengxin Fang, Kejiang Ye, Chengzhong Xu

- Archive id: arxiv:2609.37532
- Published: 2026-09-29
- arXiv: https://arxiv.org/abs/2609.37532
- Source URL: https://arxiv.org/abs/2609.37532
- PDF: https://arxiv.org/pdf/2609.37532
- Provenance: arxiv

## Abstract

Growing large language model applications demand efficient inference. At high concurrency, block-diffusion speculative decoding suffers from verification padding, rejected candidates, and incompatibility between variable prefixes and fixed-shape graphs. Uniform truncation sacrifices acceptable tokens. We present DScale, preserving drafter architecture, weights, and full draft length. A separate 112K-parameter predictor requires neither confidence calibration nor hardware speed-curve preparation. Path-aware tiles reduce padding. Dynamic verify-length (DVL) allocation packs scored prefixes into half the native verification capacity. Fixed-address workspaces propagate changing boundaries through verification and acceptance while reusing captured graphs. On A100-40GB with tensor parallelism 1, Qwen3-8B and Qwen3-4B cover four datasets and concurrency 8-32, reusing each target's frozen predictor. Geometric-mean throughput gains across these configurations are respectively 43.9% and 48.8% over DFlash, 22.2% and 37.7% over DSpark, and 24.4% and 32.0% over Domino, with lower request latency. Cumulative ablations show that adding the three mechanisms successively increases geometric-mean throughput, while budget adjustment improves accepted-token retention. GPU profiling shows that complete decode-step time on GSM8K decreases by 30.8-52.5% relative to DFlash

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.